Atai Beckley, Inc. (ATAI)
7.335
-0.02
(-0.20%)
USD |
NASDAQ |
Sep 03, 16:00
7.32
-0.02
(-0.20%)
After-Hours: 20:00
Atai Beckley Cash from Investing (Quarterly) : 158.15M for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 158.15M |
| March 31, 2026 | -21.65M |
| December 31, 2025 | -40.59M |
| September 30, 2025 | -70.68M |
| June 30, 2025 | 9.738M |
| March 31, 2025 | -11.01M |
| September 30, 2024 | 25.50M |
| June 30, 2024 | 16.19M |
| March 31, 2024 | 11.47M |
| December 31, 2023 | -0.1893M |
| September 30, 2023 | -46.80M |
| June 30, 2023 | -22.05M |
| March 31, 2023 | 16.02M |
| Date | Value |
|---|---|
| December 31, 2022 | 72.96M |
| September 30, 2022 | 69.72M |
| June 30, 2022 | -12.24M |
| March 31, 2022 | -214.74M |
| December 31, 2021 | -46.48M |
| September 30, 2021 | -0.0735M |
| June 30, 2021 | -28.32M |
| March 31, 2021 | -3.721M |
| December 31, 2020 | |
| September 30, 2020 | -6.391M |
| June 30, 2020 | -0.3025M |
| March 31, 2020 | -18.72M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Eli Lilly & Co. | -15.40B |
| GH Research Plc | 6.295M |
| Johnson & Johnson | -1.11B |
| Merck & Co., Inc. | -5.602B |
| Zoetis, Inc. | -300.00M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -35.09M |
| Cash from Financing (Quarterly) | 2.625M |
| Free Cash Flow | -134.54M |
| Free Cash Flow Per Share (Quarterly) | -0.0973 |
| Free Cash Flow to Equity (Quarterly) | -34.98M |
| Free Cash Flow to Firm (Quarterly) | -35.09M |
| Free Cash Flow Yield | -5.87% |